• Image attribution tooltip
    Courtesy of Merck & Co.

    FDA panel, after debate, narrowly backs Merck COVID pill

    While agency advisers raised concerns over molnupiravir's modest benefits and potential risks, a majority felt the antiviral drug is a needed option for COVID-19 patients at high risk of severe disease.

    By Jonathan Gardner • Updated Nov. 30, 2021
  • Image attribution tooltip
    Win McNamee via Getty Images

    Hospitals brace for omicron as margins weaken further, Kaufman Hall reports

    New uncertainties raised by the variant are likely to challenge hospitals as they grapple with shrinking operating margins as a result of escalating labor costs.

    By Susan Kelly • Dec. 1, 2021
  • Image attribution tooltip
    Permission granted by BioNTech SE

    Healthcare worker vaccine mandate blocked nationwide in second ruling

    A federal judge granted a preliminary injunction Tuesday in a suit brought by 14 states challenging the requirement, following separate pauses in other states.

    By Updated 16 hours ago
  • Image attribution tooltip
    National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Micrograph]. Retrieved from Flickr.

    Vaccine makers move quickly to confront omicron threat

    Several companies, including Pfizer and Moderna, are already at work adapting their coronavirus shots to the newly identified variant, which experts worry could more readily evade vaccine protection.

    By Ned Pagliarulo • Nov. 29, 2021
  • Image attribution tooltip
    Quinn Rooney via Getty Images

    Omicron variant not a problem for COVID-19 diagnostics, certain test makers contend

    Testing manufacturers such as Thermo Fisher Scientific, Qiagen and Lucira Health claim their tests are not impacted by the new strain, which has been designated a "variant of concern" by the World Health Organization.

    By Greg Slabodkin • Nov. 29, 2021
  • Image attribution tooltip
    Getty Images

    Biden admin investing $1.5B to quell healthcare staffing shortages, promote workforce equity

    The funding will go toward scholarship and loan repayment programs for healthcare students committing to work in hard-hit and high-risk communities, according to the White House.

    By Nov. 23, 2021
  • Image attribution tooltip
    Win McNamee via Getty Images

    Labor, supply chain pressures mount for US hospitals, Fitch says

    Staffing shortages, higher transportation costs and trouble sourcing some materials threaten healthcare revenue and operating margins in the near term, the ratings agency said.

    By Susan Kelly • Nov. 22, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    FDA, aiming to curb another COVID-19 surge, clears Pfizer, Moderna boosters for all adults

    The decision comes as at least 10 states open up booster dose eligibility beyond the current, more limited authorizations while cases remain at high levels.

    By Ben Fidler • Nov. 19, 2021